Not applicableLooking for participantsNCT07017699What this trial is testingAssess Deucravacitinib Safety in PregnancyWho this might be right forPsoriasis (PsO) Bristol-Myers Squibb 900
Large-scale testing (Phase 3)UnknownNCT06299982What this trial is testingAn Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsOWho this might be right forPlaque Psoriasis Patients Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 750
Not applicableWithdrawnNCT07255781What this trial is testingShared Pathways Between Non-Alcoholic Fatty Liver Disease and Psoriatic Disease With Guselekumab TherapyWho this might be right forPsoriasis (PsO)PsA (Psoriatic Arthritis)NAFLD (Nonalcoholic Fatty Liver Disease) University of California, San Diego
Large-scale testing (Phase 3)Looking for participantsNCT06506916What this trial is testingEvaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque PsoriasisWho this might be right forModerate to Severe Plaque PsoriasisPsoriatic Arthritis UCB Biopharma SRL 90
Not applicableLooking for participantsNCT07370766What this trial is testingImpact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in CanadaWho this might be right forPsoriasis (PsO)Moderate to Severe Psoriasis Chronicle Academy 80
Early research (Phase 1)Looking for participantsNCT06888193What this trial is testingAssess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)Who this might be right forModerate to Severe Plaque PsoriasisPsoriatic ArthritisAxial Spondyloarthritis+1 more UCB Biopharma SRL 20
Early research (Phase 1)Not Yet RecruitingNCT07455578What this trial is testingStudy of S-4321 in Participants With an Autoimmune or Immune-mediated DiseaseWho this might be right forAutoimmune DiseasesRheumatoid Arthritis (RA)Psoriatic Arthritis (PsA)+3 more Seismic Therapeutic AU Pty Ltd 24
Large-scale testing (Phase 3)Looking for participantsNCT06425549What this trial is testingEvaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque PsoriasisWho this might be right forModerate to Severe Plaque Psoriasis UCB Biopharma SRL 168
Not applicableStudy completedNCT05758402What this trial is testingA Randomized, Open, Parallel, Controlled, Multi-center, Interventional, Cross-sectional Study to Evaluate the Detection Rate of Psoriatic Arthritis in Korean Moderate-to-severe Psoriasis Patients, With or Without Active Screening for Arthritis in Psoriasis (ASAP Study)Who this might be right forPsoriasis Novartis Pharmaceuticals 368
Testing effectiveness (Phase 2)Looking for participantsNCT07233291What this trial is testingA Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in AdultsWho this might be right forPsoriasis (PsO) Ahmed Ibrahim 36
Not applicableNot Yet RecruitingNCT07390487What this trial is testingThe Effects of Audio-Based Therapy on Anxiety in PsoriasisWho this might be right forPsoriasis (PsO)Anxiety University of California, San Francisco 120
Not applicableEnded earlyNCT06715254What this trial is testingA Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in BrazilWho this might be right forTuberculosis Novartis Pharmaceuticals 152
Not applicableActive Not RecruitingNCT06897722What this trial is testingEvaluation of TNF-α, IL-17A, and YKL-40 in GCF and Serum of Psoriasis Patients and Healthy ControlsWho this might be right forPsoriasis (PsO)Periodontal Disease Zhala Vatankha Sain 100
Large-scale testing (Phase 3)Active Not RecruitingNCT06846541What this trial is testingLong-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque PsoriasisWho this might be right forPlaque PsoriasisPsoriasis (PsO)Psoriasis+2 more Alumis Inc 1,680
Not applicableStudy completedNCT02626793What this trial is testingOtezla® in Patients With Plaque Psoriasis Under Routine ConditionsWho this might be right forPsoriasis Amgen 391
Large-scale testing (Phase 3)Enrolling By InvitationNCT06982196What this trial is testingSulodexide in Controlling the Recurrence of PsoriasisWho this might be right forPsoriasis (PsO)Randomised Controlled Trial Xijing Hospital 160
Large-scale testing (Phase 3)Study completedNCT03766685What this trial is testingEvaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)Who this might be right forChronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis UCB Biopharma SRL 172
Not applicableStudy completedNCT05959070What this trial is testingAn Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO)Who this might be right forPsoriasis AbbVie 154
Large-scale testing (Phase 3)Not Yet RecruitingNCT06863493What this trial is testingComparison of Otezla to SFA-002 to Placebo in Plaque Psoriasis PatientsWho this might be right forPsoriasis (PsO) SFA Therapeutics 125
Not applicableStudy completedNCT04428411What this trial is testingStudy To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).Who this might be right forPlaque Psoriasis Pfizer 486